The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Keefe Bruyette & Woods has increased its price target for Globe Life to $180 from $168, maintaining an Outperform rating on the stock. This upward revision follows the company's Q1 2026 earnings report, which showcased a significant rise in profits and an improved full-year outlook. Similarly, Truist Securities raised its target to $185 with a Buy rating, signaling robust confidence in the firm's financial trajectory. The positive sentiment is largely driven by the updated earnings per share (EPS) guidance provided by the company management. These collective analyst upgrades highlight the strong operational performance of Globe Life within the financial services sector. Market experts anticipate that these revised targets will provide continued upward momentum for the stock in the near term.
Sign in to access this content
Sign In